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1. Introduction 
The prevalence of allergic disease and asthma has increased dramatically during the last 30-40 
years. Atopic disorders comprise a range of allergic diseases including asthma, anaphylaxis, 
allergic rhinitis, and atopic dermatitis; these diseases have been seen a precipitous increase in 
the last four decades. Intriguingly, geographic regions with a high helminth infection burden 
tend to have a lower incidence of asthma (1). The effects of parasitic infections on the incidence 
of allergic disease has been receiving increased attention from researchers of late, with studies 
conducted in Ethiopia and Gabon demonstrating that parasitic infestation is associated with 
reduced atopic sensitization and dust mite skin test sensitivity (2-4). Children treated 
repeatedly for Trichuris trichiura and Ascaris lumbricoides exhibited increased dust-mite skin 
responses as compared with children that had not been treated for asymptomatic soil-
associated helminthic infections (5). Several molecules from helminthes induce pronounced 
Th2 responses in a manner similar to that seen in cases of full-blown parasitic infection. 
Excretory-secretory (ES) glycoproteins isolated from the rodent nematode, Nippostrongylus 
brasiliensis, have been shown to evidence Th2-promoting activity on dendrite cells, however, 
the exact nature of the molecules involved in N. brasiliensis ES proteins remain to be clearly 
elucidated. This activity is heat-labile and protease-sensitive, thereby suggesting that the active 
component is proteinaceous in nature (6). Also, in schistosomiasis, the soluble extract of 
Schistosoma mansoni eggs (SEA) was shown to induce SEA-specific Th2 responses when 
injected into mice (7), and SEA was also demonstrated to condition human dendrite cells 
(DCs) to polarize Th response in a Th2 direction in vitro (8). When exposed to Th2 cytokines, 
these molecules can also activate host CD4+CD25+Foxp3+ T cells (regulatory T cells, Treg) 
which subsequently release IL-10 and tumor growth factor β (TGF-β), which may be 
functionally involved in the suppression of the level of Th2 cytokines IL-4, IL-5, and IL-13. 
These parasites can establish a chronic infection, which highlights important issues (9), in that 
the presence of these metabolically active pathogens indicates that the immune system is being 
relentlessly challenged with foreign antigens; this continuous immune reactivity, if 
uncontrolled, could eventuate severe pathology. In addition, these pathogens may have 
developed evolutionary strategies by which they may evade the immune system for long-term 
survival in an immunocompetent host (10).  
In order to ascertain, then, whether parasitic infections can reduce allergic reactions and 
whether their infective stage influences the immune system of the host, we have mimicked 
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chronic infection conditions in our experiment via treatment with parasite-derived proteins 
for one month prior to allergen treatment. We attempted to determine whether or not these 
parasite-derived proteins suppressed allergy-specific Th2 reactions. 
2. Immunization of parasite derived proteins inhibits allergic specific Th2 
response 
Long-lived parasites are highly accomplished practitioners of immune evasion and 
manipulation, utilizing strategies honed during their long co-evolutionary interaction with 
the mammalian immune system (10, 11). How is the host affected by these parasitic 
strategies? Although many hypotheses have been advanced, until the present time there has 
been little evidence to support these theories. Th2 host response as the result of parasitic 
infection was apparent, although this is the result of parasitic strategies to escape from the 
host immune system or the result of a human protective system associated with parasitic 
infection. Additionally, we could readily detect Th2 responses in allergic patients. Thus, 
until now, there has been considerable controversy regarding the relationship between 
parasites and allergic reactions; particularly, whether parasites can evoke some allergic-
specific response or can reduce allergen-specific responses (12-14).  
We have attempted to determine whether parasite-derived proteins can accelerate or reduce 
asthma symptoms in accordance with the treatment period (15). We have mimicked chronic 
infection conditions in our experiment via treatment with parasite (Toxascaris leonina adult 
worm)-derived proteins [ES protein (Tl-ES) and total proteins (Tl-TP)] for one month prior 
to the administration of allergen treatment. We mentioned this group as Immunized group; 
also Challenged with OVA group were mentioned which were administrated Tl-ES and Tl-
TP at the same challenge days in airway allergic reaction procedure. As results, the 
immunized Tl-ES and Tl-TP groups evidenced a thinning of the bronchial epithelial and 
muscle layer, a disruption and shedding of the epithelial cells, a reduction in the number of 
goblet cells as compared to the OVA-challenged groups (Fig. 1). When the airway functions 
of these mice were monitored, we detected that the Penh values by methacholine treatment 
(from 2.5 mg/ml to 25 mg/ml) were significantly higher in the OVA-inhalation mice than 
those of Tl-TP and Tl-ES immunized group (Fig. 2A). The numbers of most inflammatory 
cells (macrophages, eosinophils, lymphocytes and neutrophils) in the BAL fluids were 
significantly increased in all of the OVA-challenged groups (Fig. 2B & 2C). The 
administration of Tl-ES and Tl-TP prior to asthma induction (immunized group) and the Tl-
ES and Tl-TP with OVA challenge (challenged with OVA groups) evidenced inhibited 
recruitment of inflammatory cells into the airway (Fig. 2B & 2C). In particular, neutrophils 
and lymphocytes were significantly reduced by the parasite proteins at any administration 
time (p value < 0.05). The total number of eosinophils of the immunized and OVA-
challenged group were slightly reduced; however, this reduction was not statistically 
significant (P value > 0.05).  
Although some articles have previously asserted that nematodes can induce allergic 
reactions during their larval migration period (16, 17), many articles have reported that 
parasitic infections, particularly chronic parasitism, help to reduce host allergic reactions 
and to modulate host immune responses (14, 18, 19). We have determined that 
immunization with T. leonina adult worm ES and total proteins induces a down-regulation 
of asthma-associated cytokines, including IL-4 and IL-5, in the bronchial alveolar lavage 
(BAL) fluids (Fig. 3). However, these proteins did not significantly influence allergic airway 
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inflammation response as the result of simultaneous OVA challenge, as compared to the 
immunization method. In particular, the Tl-ES treatment with OVA challenge group 
exhibited more severe lung inflammation than was observed in the immunized group. We 
believe that certain allergens or proteases might be included in the ES proteins, and parasitic 
proteases have also been identified as allergens (20-23). Sokol et al. previously suggested 
that a host-derived sensor of proteolytic activity might involve cleavage via parasite or 
allergic proteases. This sensor, once cleaved, activates the cells of the innate immune system 
to induce a Th2 response (13).  
 
 
Fig. 1. Histological findings of airway inflammation in ova-challenged control mice and the 
effect of immunization and challenge with OVA groups. Female and 6 weeks of age mice 
were induced airway allergic reaction using intraperitoneally (I.P.) sensitizing with 75 ug of 
ovalbumin (OVA, Sigma, Grade V) and 2 mg of aluminium hydroxide gel, on days 0 and 7. 
One week after the final sensitization, the mice were intra nasal challenged with 50 ug of OVA 
on 4 consecutive days (days 13, 14, 19, and 20). We mentioned “Immunized group” that were 
injected by I.P. with 100 ul of 10 ug/ml Toxascaris leonina excretory-secretory (Tl-ES) and T. 
leonina total protein (Tl-TP), respectively, on 7 and 14 days before airway allergic reaction 
procedure. Also “Challenged with OVA” group were mentioned which were injected by I.P. 
with 100 ul of 10 ug/ml of Tl-ES and Tl-TP respectively at the same challenge days in airway 
allergic reaction procedure. The negative control group was challenged with PBS (I.N.) on the 
same challenge day in airway allergic reaction procedure. A; PBS-treated,  B-F; OVA+ alum-
treated (induced asthma), (C) immunized Tl-ES protein, (D) immunized Tl-TP, (E) Tl-ES 
protein treatment with OVA challenge, (F) Tl-TP protein with OVA challenge. 
IL-4 has been demonstrated to regulate isotype class switching in B cells to IgE synthesis, and 
IL-5 stimulates eosinophil growth, activates these cells, and prolongs eosinophil survival. T. 
leonina-derived proteins could inhibit increases in the levels of IL-4 and IL-5 from OVA 
challenge. In particular, the level of IL-4 in the BAL fluid in the immunized group was almost 
half of that observed in the OVA-only challenge group. This result was consistent with the 
results regarding the IgE concentration in the blood (15). Although levels of the IL-5 cytokine 
of T. leonina ES and total protein-immunized mice were lower than those observed in asthma 
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control mice, this effect was not remarkable. Also, the total number of eosinophils was not 
substantially reduced as the result of immunization. Eosinophils and IgE proved vitally 
important in allergy-induced Th2 response; additionally, the elevation of the numbers of these 
cells and IgE levels were identified as specific responses to parasite infection and this response 





Fig. 2. Airway hyperresponsiveness measurements and comparison of differential cell 
counts obtained via airway inflammation in ova-sensitized PBS mice and the effects in 
immunized and OVA-challenged groups. Total protein of T. leonina immunization group 
[Tl-TP (I)] has lower penh value than those of OVA challenge group (A). The numbers of 
inflammatory cells were significantly lower in the parasite-derived protein-treated mice (B 
& C). The data were expressed as the means + SD of individual mice.  
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Fig. 3. Th1 and Th2 cytokines levels in the BAL fluids of Tl-ES and Tl-TP treated mice. 
The levels of all Th2 cytokines of the immunized group were contrasted with those of the 
OVA-challenged control mice. The data were expressed as the means + SD of individual 
mice (* ; p value <0.05, **; p value <0.01).  
How does helminth infection protect against allergy? Many hypotheses have been 
advanced thus far regarding this theme. One of these hypotheses is that non-specific IgE 
generated as the result of helminthic infection may inhibit allergen-specific IgE binding 
sites on mast cells or basophils. Although Jarrett suggested in 1980 that parasite-induced 
'nonspecific' IgE does not protect against host allergic reactions (26). However, other 
scientists have suggested that nonspecific IgE can modulate host immune responses, as in 
the case of insulin-dependent diabetes, as well as Th2 response by allergens (25, 27-29). 
The other hypothesis states that helminth parasites stimulate the production of 
immunoregulatory mediators, which are likely to perform a function in the maintenance 
of the chronicity of infection, with no marked induction of pathology. In particular, 
elevated IL-10 levels have been associated previously with protection against allergic 
diseases in helminth-infected African children (4). Helminth infections can induce Treg 
cells from hosts, and these cells secrete IL-10 and suppress the proliferation of other CD4+ 
T cells (30-32). We also found that parasite proteins could also induce the IL-10 cytokine, 
particularly in the Tl-TP immunized group (Fig. 4).  
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Fig. 4. Treg cell related cytokines levels in the BAL fluids of Tl-ES and Tl-TP treated mice. 
The data were expressed as the means + SD of individual mice (* ; p value <0.05, **; p value 
<0.01).  
Finally, the data presented herein demonstrate that T. leonina-derived proteins may 
perform a crucial function in resistance against Th2 immune responses. We suggested that 
this inhibition may be related to the IL-10 cytokine, which was induced by parasite 
proteins. Further steps are currently being taken in an effort to gain a greater 
understanding of the molecular basis of immune evasion by nematodes. Thus, we are 
attempting to gain new insights into the immune regulation strategies of nematodes, and 
the growing number of new strategies employed by parasites to exert their marked down-
regulatory effects. 
3. Macrophage migration inhibitory factor homologues of parasite suppress 
Th2 response in allergic airway inflammation model via Treg cell recruitment 
A number of parasite-derived proteins, glycoconjugates, and small lipid moieties have been 
demonstrated to perform known or hypothesized functions in immune interference. Other 
researchers have already isolated several other immune downregulatory molecules from 
parasites, and these molecules have been identified as mammal cytokine homologues, 
protease inhibitors, abundant larval transcript antigens, glyco-networks, and venom 
allergen-like proteins (33-39). The cytokine network is a crucial component of host defense 
against pathogens. It is not, therefore, surprising to find that one of the immune evasion 
strategies utilized by infectious organisms is the generation of mammalian cytokine 
homologues, including TGF-β and the macrophage migration inhibitory factor (MIF)  
(40, 41).  
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MIF was described initially as one of the earliest cytokines to be derived from activated T-cells, 
and was believed to prevent the random migration of macrophages (42). MIF has also been 
demonstrated to be generated abundantly by monocytes/macrophages and to function in an 
autocrine/paracrine manner in the upregulation and sustenance of the activation of diverse 
cell types (43). The profile of the activities of MIF, both in vivo and in vitro, is reflective of a role 
for MIF in the pathogenesis of a variety of inflammatory diseases, including rheumatoid 
arthritis, inflammatory bowel disease, ankylosing spondylitis, and psoriasis (44). MIF performs 
a crucial function in airway inflammation and airway hyper-responsiveness in asthma (45).  
Recently, several MIF homologues have been isolated from parasitic nematodes. Two types 
of MIF homologues have thus far been identified in nematodes (34). The type 1 MIF 
homologues bear a greater amino acid similarity with the mammalian MIFs than do the type 
2 MIF homologues (46). The type 1 MIF homologues isolated from Brugia malayi (Bm-MIF1) 
induce eosinophil recruitment, and alternatively activated macrophage recruitment in vivo 
when injected into the peritoneal cavities of mice. Mutation of the conserved proline residue 
induces the abrogation of this activity (47). This ability of parasite MIF homologues was 
similar to those of mammalian MIF. However, recently Cho et al. reported that hookworm 
MIF (structurally type 2 MIF) functions differently from mammalian MIF (48, 49).  
We have cloned another type 2 MIF homologue (As-MIF) from Anisakis simplex (whale 
worm) 3rd stage larva, which causes anisakidosis in humans (50). Recombinant As-MIF (rAs-
MIF) proved highly effective with regard to the inhibition of goblet cell hyperplasia and 
inflammatory responses in the airways of OVA-induced asthma model mice (Fig. 5). 
Increasing concentrations of rAs-MIF induced an increase in the anti-inflammatory effects 
on asthma model mice. Additionally, the function of rAs-MIF was antagonized as compared 
to the function of host MIF (59).  
How does As-MIF suppress allergy responses in mice? There have been many reports 
demonstrating that Th2-type effector responses may be regulated by Treg cells (51-53). 
Additionally, nematode infections can induce and expand naturally occurring Treg cells in 
both humans and mice (4, 54), thereby suggesting a role for these Treg cells in the helminth-
induced modulation of inflammatory diseases (55, 56). In particular, the clinical symptoms 
of allergic airway inflammation in the mouse model was clearly modulated by Treg cell 
mediated immune suppression, which was itself activated by helminth infection or antigen 
treatment (57, 58). We could determine the increase in Treg cells as the result of rAs-MIF 
treatment in OVA-alum asthma-induced mice (Fig. 6).  
IL-10 and TGF-β were produced primarily by Treg cells, and they are known to suppress 
immune response effects. The IL-10 and TGF-β levels measured in BALFs from rAs-MIF-
treated asthma-induced mice were higher than those of the asthma-induced mice; the IL-10 
and TGF-β levels occurred in accordance with their treated concentrations (59). The 
helminthic parasites stimulate the production of immunoregulatory mediators, which likely 
perform a function in the maintenance of the chronicity of infection, without any marked 
induction of pathology. In particular, elevated IL-10 levels have been associated with 
responses against allergic diseases in helminth-infected individuals (4). Also, Nagler-
Anderson et al. showed that in mice sensitized with peanut plus cholera toxin, anti-IL-10 
treatment abrogated the ability of helminths to protect against allergic symptoms and to 
downregulate allergen-specific IgE. IL-10, which is referred to as the cytokine synthesis 
inhibitory factor, is an anti-inflammatory cytokine, which is capable of inhibiting the 
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synthesis of pro-inflammatory cytokines (60). The IL-10 requirement is critical to several 
important human diseases, including schistosomiasis, wherein marked increases in host 
morbidity and mortality are observed when IL-10 levels are low or absent (61). In cases of 
murine S. mansoni infection, IL-10 attenuates the hepatocyte damage induced by the eggs of 
the parasite. IL-10 is also essential for the maintenance of non-lethal chronic infections, in 
addition to the inhibition of inappropriate immune responses in experimental models (62). 
TGF-β1 is also a strong candidate for immune suppression by Treg cells from helminth-
infected mice, and has already been recognized to alleviate experimental airway allergy 
symptoms (63) and to instruct peripheral T cells to develop their regulatory capacities (64). 
Thus, the inhibition of asthma response by rAs-MIF may be associated with the principal 




Fig. 5. Histologic appearance of lungs after challenge with PBS, OVA, and rAs-MIF by 
concentration (H-E stain). (A; x 100, B; x 600; C; PAS stain), C; a, f, and k; phosphate-
buffered saline (PBS) treated, b-e, g-j, and l-o; OVA plus alum-treated (induced asthma), c, h 
and m; challenged with 1 μg/ml rAs-MIF, d, i, and n; challenged with 10 μg/ml rAs-MIF. e, 
j, and o; challenged with 100μg/ml rAs-MIF. In asthma-induced mice, a massive peri-
bronchial infiltration with immune-related cells and hyperplasia of bronchial epithelial cells 
were observed. Upon challenge with 1μg/ml rAs-MIF treatment (c, h and m), asthma-
induced mice evidenced thinner bronchial epithelial cells than were observed in the asthma-
induced mice (b, g, and l). Mice challenged with treatment with 10 and 100μg/ml rAs-MIF 
evidenced thinner than normal bronchial epithelial cells and decreased numbers of immune-
related cells. Goblet cells and immune-related cells in the airway walls of mice exposed to 
PBS, OVA and OVA challenge with 1, 10, and 100 μg/ml rAs-MIF. In asthma-induced mice 
(g), a massive peri-bronchial infiltration of inflammatory cells and hyperplasia of bronchial 
epithelial cells were detected. However, goblet cell hyperplasia was reduced in the bronchial 
epithelial cells of the rAs-MIF-treated mice (h-j).  
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Fig. 6. Treg cell production could be induced by rAs-MIF treatment. Treg cell populations in 
the lungs and spleen were significantly increased by rAs-MIF treatment, but this effect was 
inhibited by rAnti-As-MIF. (*; p < 0. 05, **; p < 0.01, n = 5 mice per group, 3 independent 
experiments). 
4. Conclusion 
We showed that parasite derived proteins may perform a crucial function in resistance 
against allergic airway inflammation via IL-10 cytokine induction and Treg cell recruitment. 
Parasites regulate or suppress their host immune response, maintaining their parasitism for 
a prolonged period, using unknown molecules. As-MIF might be one of the molecules that 
affect host immune regulation. The further characterization of parasite derived proteins 
might ultimately result in the design of novel therapeutic intervention strategies for the 
treatment of asthma.  
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